197 related articles for article (PubMed ID: 18703951)
1. Comparison of the effects of latanoprost and bimatoprost on central corneal thickness.
Sen E; Nalcacioglu P; Yazici A; Aksakal FN; Altinok A; Tuna T; Koklu G
J Glaucoma; 2008 Aug; 17(5):398-402. PubMed ID: 18703951
[TBL] [Abstract][Full Text] [Related]
2. The comparison of the effects of latanoprost, travoprost, and bimatoprost on central corneal thickness.
Zhong Y; Shen X; Yu J; Tan H; Cheng Y
Cornea; 2011 Aug; 30(8):861-4. PubMed ID: 21499083
[TBL] [Abstract][Full Text] [Related]
3. Switching efficacy on intraocular pressure from latanoprost to bimatoprost in eyes with open angle glaucoma: implication to the changes of central corneal thickness.
Sawada A; Yamamoto T
Jpn J Ophthalmol; 2014 Sep; 58(5):423-8. PubMed ID: 25004992
[TBL] [Abstract][Full Text] [Related]
4. A comparison of long-term intraocular pressure fluctuation in patients treated with bimatoprost or latanoprost.
Simmons ST; Bernstein P; Hollander DA
Am J Ophthalmol; 2008 Sep; 146(3):473-7. PubMed ID: 18561893
[TBL] [Abstract][Full Text] [Related]
5. A comparison of bimatoprost 0.03% versus the fixed-combination of latanoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial.
Facio AC; Reis AS; Vidal KS; de Moraes CG; Suzuki R; Hatanaka M; Susanna R
J Ocul Pharmacol Ther; 2009 Oct; 25(5):447-51. PubMed ID: 19860553
[TBL] [Abstract][Full Text] [Related]
6. Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost.
Gandolfi SA; Cimino L
Ophthalmology; 2003 Mar; 110(3):609-14. PubMed ID: 12623831
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.
Rossetti L; Karabatsas CH; Topouzis F; Vetrugno M; Centofanti M; Boehm A; Viswanathan A; Vorwerk C; Goldblum D
Ophthalmology; 2007 Dec; 114(12):2244-51. PubMed ID: 17459480
[TBL] [Abstract][Full Text] [Related]
8. Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension.
Whitson JT; Trattler WB; Matossian C; Williams J; Hollander DA
J Ocul Pharmacol Ther; 2010 Jun; 26(3):287-92. PubMed ID: 20578283
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
Orzalesi N; Rossetti L; Bottoli A; Fogagnolo P
Ophthalmology; 2006 Feb; 113(2):239-46. PubMed ID: 16458092
[TBL] [Abstract][Full Text] [Related]
10. The effect of prostaglandin analogs and prostamide on central corneal thickness.
Hatanaka M; Vessani RM; Elias IR; Morita C; Susanna R
J Ocul Pharmacol Ther; 2009 Feb; 25(1):51-3. PubMed ID: 19232014
[TBL] [Abstract][Full Text] [Related]
11. 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.
Walters TR; DuBiner HB; Carpenter SP; Khan B; VanDenburgh AM;
Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S26-35. PubMed ID: 15016559
[TBL] [Abstract][Full Text] [Related]
12. [Prostaglandin analogues and central corneal thickness].
Stefan C; Dumitrica DM; Tebeanu E; Nae I; Sapundgieva A; Dragomir L
Oftalmologia; 2007; 51(4):95-9. PubMed ID: 18543683
[TBL] [Abstract][Full Text] [Related]
13. A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure.
Choplin N; Bernstein P; Batoosingh AL; Whitcup SM;
Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S19-25. PubMed ID: 15016558
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trial.
Koz OG; Ozsoy A; Yarangumeli A; Kose SK; Kural G
Acta Ophthalmol Scand; 2007 Dec; 85(8):838-43. PubMed ID: 17680841
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance Organization.
Law SK; Song BJ; Fang E; Caprioli J
Ophthalmology; 2005 Dec; 112(12):2123-30. PubMed ID: 16225924
[TBL] [Abstract][Full Text] [Related]
16. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
[TBL] [Abstract][Full Text] [Related]
17. The effects of prostaglandin analogues on the blood aqueous barrier and corneal thickness of phakic patients with primary open-angle glaucoma and ocular hypertension.
Arcieri ES; Pierre Filho PT; Wakamatsu TH; Costa VP
Eye (Lond); 2008 Feb; 22(2):179-83. PubMed ID: 16936646
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of bimatoprost versus travoprost in patients previously on latanoprost: a 3-month, randomised, masked-evaluator, multicentre study.
Kammer JA; Katzman B; Ackerman SL; Hollander DA
Br J Ophthalmol; 2010 Jan; 94(1):74-9. PubMed ID: 19726422
[TBL] [Abstract][Full Text] [Related]
19. Randomized crossover study of latanoprost and travoprost in eyes with open-angle glaucoma.
Sawada A; Yamamoto T; Takatsuka N
Graefes Arch Clin Exp Ophthalmol; 2012 Jan; 250(1):123-9. PubMed ID: 21858678
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of latanoprost and bimatoprost on intraocular pressure in chronic angle-closure glaucoma.
Chen MJ; Chen YC; Chou CK; Hsu WM
J Ocul Pharmacol Ther; 2007 Dec; 23(6):559-66. PubMed ID: 18001247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
